Paris - Delayed Quote EUR

Sensorion SA (ALSEN.PA)

0.3200
-0.0100
(-3.03%)
At close: May 23 at 5:35:11 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
4,023.4970
3,335.1990
Operating Expense
28,401
28,401
22,310
27,122.8050
18,336.8090
Operating Income
-28,401
-28,401
-22,310
-23,099.3080
-15,001.6100
Net Non Operating Interest Income Expense
2,548
2,548
598
-109.7810
-135.1780
Pretax Income
-25,846
-25,846
-21,766
-23,209.0900
-15,136.7890
Tax Provision
126
126
297
0
0
Net Income Common Stockholders
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Diluted NI Available to Com Stockholders
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Basic EPS
-0.09
-0.09
-0.18
-0.29
-0.19
Diluted EPS
-0.09
-0.09
-0.18
-0.29
-0.19
Basic Average Shares
283,969.1290
283,969.1290
122,501.5380
79,837.0840
79,691.3580
Diluted Average Shares
283,969.1290
283,969.1290
122,501.5380
79,837.0840
79,691.3580
Total Operating Income as Reported
-28,401
-28,401
-22,310
-23,136.6480
-15,024.5970
Rent Expense Supplemental
77.7230
--
52.0960
32.9360
111.7470
Total Expenses
28,401
28,401
22,310
27,122.8050
18,336.8090
Net Income from Continuing & Discontinued Operation
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Normalized Income
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Interest Income
2,878
2,878
708
95.5720
53.5520
Interest Expense
251
251
109
168.0140
165.7440
Net Interest Income
2,548
2,548
598
-109.7810
-135.1780
EBIT
-25,595
-25,595
-21,657
-23,041.0760
-14,971.0450
EBITDA
-25,417
-25,417
-21,490
-22,275.1510
-14,475.5270
Reconciled Depreciation
178
178
167
765.9250
495.5180
Net Income from Continuing Operation Net Minority Interest
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Normalized EBITDA
-25,417
-25,417
-21,490
-22,275.1510
-14,475.5270
Tax Rate for Calcs
0.0003
0.0003
0.0003
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/21/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OSE.PA OSE Immunotherapeutics SA
6.08
-4.48%
 
IPH.PA Innate Pharma S.A.
1.9620
-0.30%
 
ALCLS.PA Cellectis S.A.
1.4160
+5.99%
 
POXEL.PA Poxel S.A.
0.4390
-3.83%
 
ADOC.PA Adocia SA
3.5700
-4.03%
 
ALNEV.PA Neovacs S.A.
0.0050
+4.17%
 
ALTHX.PA Theranexus Société Anonyme
1.0150
-2.40%
 
TNG.PA Transgene SA
0.6100
+8.54%
 
ABVX.PA ABIVAX Société Anonyme
5.06
-3.07%
 
GNFT.PA Genfit S.A.
3.8680
-4.59%